Status:
UNKNOWN
Clinical Proof-of-concept Study on Rapid Immune Modulating Effects
Lead Sponsor:
Natural Immune Systems Inc
Conditions:
Immune Surveillance
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Clinical-proof-of concept study, comparing the acute immune impacts of of 2 doses of a novel blend of supplements to a placebo. This study involves twenty-four participants, composed of healthy adults...
Detailed Description
Clinical-proof-of-concept study comparing the acute immune effects of 2 doses of a nutraceutical blend, and a placebo. The nutraceutical blend is based on a transfer factor isolated from cow colostrum...
Eligibility Criteria
Inclusion
- Healthy adults
- Veins easy to see in one or both arms
- Willing to comply with study procedures, including
- Maintaining a consistent diet and lifestyle routine throughout the study;
- Consistent habit of bland breakfast on days of clinic visits
- Abstaining from exercising on and nutritional supplements on the morning of a study visit;
- Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit;
- Abstaining from music, candy, gum, computer/cell phone use, during clinic visits
Exclusion
- Previous major gastrointestinal surgery
- Taking anti-inflammatory medications on a daily basis
- Currently experiencing intense stressful events/life changes
- Currently in intensive athletic training (such as marathon runner)
- Currently taking antipsychotic medications such as clozapine, Risperdal, Abilify, Zyprexa or Seroquel
- An unusual sleep routine
- Unwilling to maintain a constant intake of supplements over the duration of the study
- Anxiety about having blood drawn
- People of childbearing potential: Pregnant, nursing, or trying to become pregnant
- Known food sensitivities related to ingredients in active test product placebo Prescription medication evaluated on a cas-by-case basis
Key Trial Info
Start Date :
May 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05364710
Start Date
May 7 2022
End Date
June 1 2023
Last Update
May 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIS Labs
Klamath Falls, Oregon, United States, 97601